Syndax Pharmaceuticals, Inc. (SNDX) Shareholder/Analyst Call Prepared Remarks Transcript
Source: SeekingAlpha
2026-06-10 13:12:10 ET
Syndax Pharmaceuticals, Inc. (SNDX) Shareholder/Analyst Call June 10, 2026 12:00 PM EDT...
Read the full article on Seeking Alpha
For further details see:
Syndax Pharmaceuticals, Inc. (SNDX) Shareholder/Analyst Call Prepared Remarks Transcript
Syndax Pharmaceuticals Inc.
NASDAQ: SNDX
SNDX Trading
-2.71% G/L:
$22.46 Last:
707,324 Volume:
$22.95 Open:
SNDX Latest News
June 11, 2026 07:03:00 am
Syndax Showcases Revuforj® (revumenib) Clinical Activity in Multiple Acute Leukemia Subtypes and Settings at EHA 2026
June 11, 2026 07:00:00 am
Syndax Announces Publication of SAVE Data on Revuforj® (revumenib) in Combination with Decitabine/Cedazuridine and Venetoclax in Relapsed/Refractory NPM1m, KMT2Ar, and NUP98r AML in the Journal of Clinical Oncology
June 04, 2026 07:00:00 am
Syndax Announces Private Placement of $250.0 Million of Convertible Senior Notes
$1,884,313,688
83,351,330
1.17%
104
N/A
Biotechnology & Life Sciences
Healthcare
US
NEW YORK
